Murine and human autotaxin α, β, and γ isoforms -: Gene organization, tissue distribution, and biochemical characterization

被引:99
作者
Giganti, Adeline [1 ]
Rodriguez, Marianne [1 ]
Fould, Benjamin [1 ]
Moulharat, Natacha [1 ]
Coge, Francis [1 ]
Chomarat, Pascale [1 ]
Galizzi, Jean-Pierre [1 ]
Valet, Philippe [2 ]
Saulnier-Blache, Jean-Sebastien [2 ]
Boutin, Jean A. [1 ]
Ferry, Gilles [1 ]
机构
[1] Inst Rech Servier, F-78290 Croissy sur Seine, France
[2] INSERM, U 858 12MR, Dept Metab & Obes, F-31432 Toulouse, France
关键词
D O I
10.1074/jbc.M708705200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autotaxin is a type II ectonucleotide pyrophosphate phosphodiesterase enzyme. It has been recently discovered that it also has a lysophospholipase D activity. This enzyme probably provides most of the extracellular lysophosphatidic acid from lysophosphatidylcholine. The cloning and tissue distribution of the three isoforms (imaginatively called alpha, beta, and gamma) from human and mouse are reported in this study, as well as their tissue distribution by PCR in the human and mouse. The fate of the alpha isoform from human was also studied after purification and using mass spectrometry. Indeed, this particular isoform expresses the intron 12 in which a cleavage site is present, leading to a rapid catabolism of the isoform. For the human isoform gamma and the total autotaxin mRNA expression, quantitative PCR is presented in 21 tissues. The isoforms were expressed in two different hosts, insect cells and Chinese hamster ovary cells, and were highly purified. The characteristics of the six purified isoforms (pH and temperature dependence, K-m and V-max values, and their dependence on metal ions) are presented in this study. Their sensitivity to a small molecule inhibitor, hypericin, is also shown. Finally, the specificity of the isoforms toward a large family of lysophosphatidylcholines is reported. This study is the first complete description of the reported autotaxin isoforms.
引用
收藏
页码:7776 / 7789
页数:14
相关论文
共 59 条
  • [51] Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
    Umezu-Goto, M
    Kishi, Y
    Taira, A
    Hama, K
    Dohmae, N
    Takio, K
    Yamori, T
    Mills, GB
    Inoue, K
    Aoki, J
    Arai, H
    [J]. JOURNAL OF CELL BIOLOGY, 2002, 158 (02) : 227 - 233
  • [52] Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes -: A paracrine signal for preadipocyte growth
    Valet, P
    Pagès, C
    Jeanneton, O
    Daviaud, D
    Barbe, P
    Record, M
    Saulnier-Blache, JS
    Lafontan, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07) : 1431 - 1438
  • [53] Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate
    van Meeteren, LA
    Ruurs, P
    Christodoulou, E
    Goding, JW
    Takakusa, H
    Kikuchi, K
    Perrakis, A
    Nagano, T
    Moolenaar, WH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (22) : 21155 - 21161
  • [54] Regulation and biological activities of the autotaxin-LPA axis
    van Meeteren, Laurens A.
    Moolenaar, Wouter H.
    [J]. PROGRESS IN LIPID RESEARCH, 2007, 46 (02) : 145 - 160
  • [55] Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development
    van Meeteren, Laurens A.
    Ruurs, Paula
    Stortelers, Catelijne
    Bouwman, Peter
    van Rooijen, Marga A.
    Pradere, Jean Philippe
    Pettit, Trevor R.
    Wakelam, MiChael J. O.
    Saulnier-Blache, Jean Sebastien
    Mummery, Christine L.
    Moolenaar, Wouter H.
    Jonkers, Jos
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (13) : 5015 - 5022
  • [56] WYKLE RL, 1974, J BIOL CHEM, V249, P1742
  • [57] STUDIES OF LYSOPHOSPHOLIPASE-D OF RAT-LIVER AND OTHER TISSUES
    WYKLE, RL
    KRAEMER, WF
    SCHREMMER, JM
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1977, 184 (01) : 149 - 155
  • [58] Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells
    Yang, SY
    Lee, J
    Park, CG
    Kim, S
    Hong, SY
    Chung, HC
    Min, SK
    Han, JW
    Lee, HW
    Lee, HY
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (07) : 603 - 608
  • [59] Zhou M, 2000, P SPIE INT SOC OPT E, V3926, P166